|
|
|
|
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
|
Laporte Road, Stallingborough
|
|
|
|
Grimsby, North East Lincolnshire, DN40 2PR, UK
|
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Title of each class
|
Trading Symbol(s)
|
Name of exchange on which registered
|
|
|
|
|
| Item 2.02. |
Results of Operations and Financial Condition.
|
| Item 9.01. |
Financial Statements and Exhibits.
|
|
Exhibit
No.
|
Description
|
|
| 99.1 |
Press Release, dated February 17, 2021 reporting Tronox Holdings plc’s financial results for the fourth quarter 2020.
|
|
|
104
|
Inline XBRL for the cover page of this Current Report on Form 8-K.
|
|
TRONOX HOLDINGS PLC
|
|||
|
Date: February 18, 2021
|
By:
|
/s/ Jeffrey Neuman
|
|
| Name: |
Jeffrey Neuman
|
||
| Title: |
Senior Vice President, General Counsel and Secretary
|
||
| • |
Revenue of $783 million
|
| • |
Income from operations of $94 million; Net income from continuing operations of $57 million
|
| • |
Adjusted EBITDA of $204 million; Adjusted EBITDA margin of 26 percent (Non-GAAP)
|
| • |
GAAP diluted EPS of $0.31; Adjusted diluted EPS of $0.19 (Non-GAAP)
|
| • |
TiO2 selling prices remained level, benefiting from margin stability initiatives, and sales volumes increased 8 percent versus fourth quarter 2019 driven by improved market demand globally
|
| • |
Zircon volumes increased 48 percent versus fourth quarter 2019 driven primarily by strong demand in China
|
| • |
Revenue of $2,758 million
|
| • |
Income from operations of $271 million; Net income from continuing operations of $995 million
|
| • |
Adjusted EBITDA of $668 million; Adjusted EBITDA margin of 24 percent (Non-GAAP)
|
| • |
GAAP diluted income per share from continuing operations of $6.69; Adjusted diluted EPS of $0.56 (Non-GAAP)
|
| • |
Total acquisition synergies of $243 million achieved, exceeding run rate synergy target of $220 million set at Investor Day in 2019; $193 million reflected in EBITDA, exceeding $183 million target set on third quarter 2020 earnings call
|
| • |
Cash flow provided by operating activities of $355 million; Free Cash Flow of $160 million (Non-GAAP)
|
| • |
$200 million discretionary debt repayment made in December 2020
|
| • |
$300 million discretionary debt repayment expected to be made by end of Q1 2021 from cash on the balance sheet
|
| • |
Increased annualized dividend to $0.32 per share, equivalent to a 14 percent increase, effective when the normal first quarter 2021 dividend is expected to be declared
|
| • |
Q1 2021 Outlook:
|
| – |
TiO2 sales volumes expected to increase 11-15 percent sequentially from global demand strength
|
| – |
Q1 2021 Adjusted EBITDA outlook of $200-$210 million
|
|
(Millions of dollars)
|
Q4 2020
|
Q4 2019
|
Y-o-Y
|
%∆
|
Q3 2020
|
Q-o-Q
|
%∆
|
|||||||||||||
|
Revenue
|
$
|
783
|
$
|
693
|
13
|
%
|
$
|
675
|
16
|
%
|
||||||||||
|
TiO2
|
587
|
544
|
8
|
%
|
543
|
8
|
%
|
|||||||||||||
|
Zircon
|
94
|
71
|
32
|
%
|
56
|
68
|
%
|
|||||||||||||
|
Feedstock and other products
|
102
|
78
|
31
|
%
|
76
|
34
|
%
|
|||||||||||||
|
Net Income from Continuing Ops
|
57
|
1
|
n/
|
m
|
902
|
n/
|
m
|
|||||||||||||
|
Adjusted EBITDA
|
204
|
156
|
31
|
%
|
148
|
38
|
%
|
|||||||||||||
|
Adjusted EBITDA Margin %
|
26
|
%
|
23
|
%
|
3 pts
|
22
|
%
|
4 pts
|
||||||||||||
| Y-o-Y% ∆ | Q-o-Q% ∆ | ||||||||||||||||
|
Volume
|
Price
|
Volume
|
Price
|
||||||||||||||
|
TiO2
|
8
|
%
|
0
|
%
|
8
|
%
|
0
|
%
|
|||||||||
|
Local Currency Basis
|
n/a
|
(2
|
%)
|
n/a
|
0
|
%
|
|||||||||||
|
Zircon
|
48
|
%
|
(10
|
%)
|
70
|
%
|
(2
|
%)
|
|||||||||
| • |
Revenue of $783 million increased 13 percent compared to $693 million
|
| • |
TiO2 sales of $587 million increased 8 percent compared to $544 million; sales volumes increased 8 percent versus the year ago quarter driven by market recovery and a positive deviation from normal seasonal trends; selling
prices remain unchanged on a U.S. dollar basis and declined 2 percent on a local currency basis year over year
|
| • |
Zircon sales of $94 million increased 32 percent from $71 million; sales volumes improved 48 percent primarily due to demand recovery in China while selling prices were 10 percent lower
|
| • |
Feedstock and other products sales of $102 million increased 31 percent from $78 million due to improved pig iron demand
|
| • |
Adjusted EBITDA of $204 million increased 31 percent compared to $156 million, driven primarily by higher sales volumes, acquisition synergies, and favorable exchange rates, partially offset by lower pricing and increased production
costs due to higher fixed cost absorption; includes $4 million of reimbursement from claims related to the Ginkgo concentrator failure we inherited as part of the Cristal transaction
|
| • |
Selling, general and administrative (“SG&A”) expenses were $84 million compared to $92 million
|
| • |
Interest expense of $49 million increased from $47 million in the year-ago quarter
|
| • |
Revenue of $783 million increased 16 percent compared to $675 million
|
| • |
TiO2 sales of $587 million increased 8 percent compared to $543 million; sales volumes increased 8 percent driven by continued recovery across all markets and geographies and a positive deviation from normal seasonal trends;
selling prices remained level sequentially on both a U.S. dollar and local basis
|
| • |
Zircon sales of $94 million increased 68 percent from $56 million, driven by a 70 percent increase in sales volumes due to demand recovery in China and some benefit from shipment timing between quarters while selling prices declined 2
percent
|
| • |
Feedstock and other products sales of $102 million increased 34 percent compared to $76 million, due to improved sales volumes of pig iron
|
| • |
Adjusted EBITDA of $204 million increased 38 percent compared to $148 million, driven primarily by improved sales volumes, improved production costs, and synergies, partially offset by exchange rate headwinds; includes $4 million of
reimbursement from claims related to the Ginkgo concentrator failure we inherited as part of the Cristal transaction
|
| • |
SG&A expenses were $84 million compared to $89 million
|
| • |
Interest expense was $49 million compared to $48 million
|
| • |
As of December 31, 2020, debt was $3.3 billion and debt, net of cash and cash equivalents was $2.7 billion
|
| • |
Liquidity was $1.0 billion as of December 31, 2020, comprised of cash and cash equivalents of $619 million and $422 million available under revolving credit agreements
|
| • |
Restricted cash of $29 million includes $18 million which was released as a break fee in January 2021 related to the TTI acquisition
|
| • |
FY 2020 capital expenditures were $195 million
|
| • |
FY 2020 depreciation, depletion and amortization expense was $304 million
|
| • |
Free Cash Flow for the year was $160 million
|
| • |
Alembic Global Advisors Chemical & Industrial Conference (Virtual), February 26, 2021
|
| • |
NYSE Basic Materials Access Day (Virtual), March 9, 2021
|
| • |
Fermium ESG Forum (Virtual), March 24, 2021
|
|
Three Months Ended December 31,
|
Year Ended December 31,
|
|||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
Net sales
|
$
|
783
|
$
|
693
|
$
|
2,758
|
$
|
2,642
|
||||||||
|
Cost of goods sold
|
605
|
545
|
2,137
|
2,159
|
||||||||||||
|
Contract loss
|
-
|
-
|
-
|
19
|
||||||||||||
|
Gross profit
|
178
|
148
|
621
|
464
|
||||||||||||
|
Selling, general and administrative expenses
|
84
|
95
|
347
|
347
|
||||||||||||
|
Restructuring
|
-
|
9
|
3
|
22
|
||||||||||||
|
Income from operations
|
94
|
44
|
271
|
95
|
||||||||||||
|
Interest expense
|
(49
|
)
|
(47
|
)
|
(189
|
)
|
(201
|
)
|
||||||||
|
Interest income
|
2
|
2
|
8
|
18
|
||||||||||||
|
Loss on extinguishment of debt
|
(2
|
)
|
(1
|
)
|
(2
|
)
|
(3
|
)
|
||||||||
|
Other income (expense), net
|
7
|
1
|
26
|
3
|
||||||||||||
|
Income (loss) from continuing operations before income taxes
|
52
|
(1
|
)
|
114
|
(88
|
)
|
||||||||||
|
Income tax benefit (provision)
|
5
|
(4
|
)
|
881
|
(14
|
)
|
||||||||||
|
Net income (loss) from continuing operations
|
57
|
(5
|
)
|
995
|
(102
|
)
|
||||||||||
|
Net income from discontinued operations, net of tax
|
-
|
-
|
-
|
5
|
||||||||||||
|
Net income (loss)
|
57
|
(5
|
)
|
995
|
(97
|
)
|
||||||||||
|
Net income attributable to noncontrolling interest
|
12
|
(5
|
)
|
26
|
12
|
|||||||||||
|
Net income (loss) attributable to Tronox Holdings plc
|
$
|
45
|
$
|
-
|
$
|
969
|
$
|
(109
|
)
|
|||||||
|
Net income (loss) per share, basic:
|
||||||||||||||||
|
Continuing operations
|
$
|
0.31
|
$
|
-
|
$
|
6.76
|
$
|
(0.81
|
)
|
|||||||
|
Discontinued operations
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
0.03
|
||||||||
|
Net income (loss) per share, basic
|
$
|
0.31
|
$
|
-
|
$
|
6.76
|
$
|
(0.78
|
)
|
|||||||
|
Net income (loss) per share, diluted:
|
||||||||||||||||
|
Continuing operations
|
$
|
0.31
|
$
|
-
|
$
|
6.69
|
$
|
(0.81
|
)
|
|||||||
|
Discontinued operations
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
0.03
|
||||||||
|
Net income (loss) per share, diluted
|
$
|
0.31
|
$
|
-
|
$
|
6.69
|
$
|
(0.78
|
)
|
|||||||
|
Weighted average shares outstanding, basic (in thousands)
|
143,621
|
141,923
|
143,355
|
139,859
|
||||||||||||
|
Weighted average shares outstanding, diluted (in thousands)
|
147,254
|
141,923
|
144,906
|
139,859
|
||||||||||||
|
Other Operating Data:
|
||||||||||||||||
|
Capital expenditures
|
66
|
58
|
195
|
198
|
||||||||||||
|
Depreciation, depletion and amortization expense
|
85
|
75
|
304
|
280
|
||||||||||||
|
Three Months Ended December 31,
|
Year Ended December 31,
|
|||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
Net income (loss) attributable to Tronox Holdings plc (U.S. GAAP)
|
$
|
45
|
$
|
-
|
$
|
969
|
$
|
(109
|
)
|
|||||||
|
Net income from discontinued operations, net of tax (U.S. GAAP)
|
-
|
-
|
-
|
5
|
||||||||||||
|
Net income (loss) from continuing operations attributable to Tronox Holdings plc (U.S. GAAP)
|
$
|
45
|
$
|
-
|
$
|
969
|
$
|
(114
|
)
|
|||||||
|
Inventory step-up (a)
|
-
|
2
|
-
|
91
|
||||||||||||
|
Contract loss (b)
|
-
|
-
|
-
|
14
|
||||||||||||
|
Transaction costs (c)
|
4
|
3
|
14
|
32
|
||||||||||||
|
Restructuring (d)
|
-
|
8
|
3
|
21
|
||||||||||||
|
Integration costs (e)
|
-
|
8
|
10
|
16
|
||||||||||||
|
Loss on extinguishment of debt (f)
|
2
|
1
|
2
|
3
|
||||||||||||
|
Pension settlement and curtailment gains (g)
|
(2
|
)
|
(1
|
)
|
(2
|
)
|
(1
|
)
|
||||||||
|
Insurance proceeds (h)
|
(8
|
)
|
-
|
(11
|
)
|
-
|
||||||||||
|
Other (i)
|
2
|
-
|
4
|
-
|
||||||||||||
|
Tax valuation allowance (j)
|
(10
|
)
|
-
|
(903
|
)
|
-
|
||||||||||
|
Charge for capital gains tax payment to Exxaro (k)
|
-
|
(2
|
)
|
-
|
4
|
|||||||||||
|
Income tax expense - deferred tax assets (l)
|
(5
|
)
|
-
|
(5
|
)
|
-
|
||||||||||
|
Adjusted net income from continuing operations attributable to Tronox Holdings plc (non-U.S. GAAP) (1)(2)
|
$
|
28
|
$
|
19
|
$
|
81
|
$
|
66
|
||||||||
|
Diluted net income (loss) per share from continuing operations (U.S. GAAP)
|
$
|
0.31
|
$
|
-
|
$
|
6.69
|
$
|
(0.81
|
)
|
|||||||
|
Inventory step-up, per share
|
-
|
0.01
|
-
|
0.65
|
||||||||||||
|
Contract loss, per share
|
-
|
-
|
-
|
0.10
|
||||||||||||
|
Transaction costs, per share
|
0.03
|
0.02
|
0.10
|
0.23
|
||||||||||||
|
Restructuring, per share
|
-
|
0.06
|
0.02
|
0.15
|
||||||||||||
|
Integration costs, per share
|
-
|
0.06
|
0.07
|
0.11
|
||||||||||||
|
Loss on extinguishment of debt, per share
|
0.01
|
0.01
|
0.01
|
0.02
|
||||||||||||
|
Pension settlement and curtailment gains, per share
|
(0.01
|
)
|
(0.01
|
)
|
(0.01
|
)
|
(0.01
|
)
|
||||||||
|
Insurance proceeds, per share
|
(0.05
|
)
|
-
|
(0.08
|
)
|
-
|
||||||||||
|
Other, per share
|
0.01
|
-
|
0.03
|
-
|
||||||||||||
|
Tax valuation allowance, per share
|
(0.07
|
)
|
-
|
(6.24
|
)
|
-
|
||||||||||
|
Charge for capital gains tax payment to Exxaro, per share
|
-
|
(0.01
|
)
|
-
|
0.03
|
|||||||||||
|
Income tax expense - deferred tax assets, per share
|
(0.04
|
)
|
-
|
(0.03
|
)
|
-
|
||||||||||
|
Diluted adjusted net income per share from continuing operations attributable to Tronox Holdings plc (non-U.S. GAAP)
|
$
|
0.19
|
$
|
0.14
|
$
|
0.56
|
$
|
0.47
|
||||||||
|
Weighted average shares outstanding, diluted (in thousands)
|
147,254
|
143,124
|
144,906
|
140,961
|
||||||||||||
|
December 31, 2020
|
December 31, 2019
|
|||||||
|
ASSETS
|
||||||||
|
Current Assets
|
||||||||
|
Cash and cash equivalents
|
$
|
619
|
$
|
302
|
||||
|
Restricted cash
|
29
|
9
|
||||||
|
Accounts receivable (net of allowance of $5 in 2020 and $5 in 2019)
|
540
|
482
|
||||||
|
Inventories, net
|
1,137
|
1,131
|
||||||
|
Prepaid and other assets
|
200
|
143
|
||||||
|
Income taxes receivable
|
4
|
6
|
||||||
|
Total current assets
|
2,529
|
2,073
|
||||||
|
Noncurrent Assets
|
||||||||
|
Property, plant and equipment, net
|
1,759
|
1,762
|
||||||
|
Mineral leaseholds, net
|
803
|
852
|
||||||
|
Intangible assets, net
|
201
|
208
|
||||||
|
Lease right of use assets, net
|
81
|
101
|
||||||
|
Deferred tax assets
|
1,020
|
110
|
||||||
|
Other long-term assets
|
175
|
162
|
||||||
|
Total assets
|
$
|
6,568
|
$
|
5,268
|
||||
|
LIABILITIES AND EQUITY
|
||||||||
|
Current Liabilities
|
||||||||
|
Accounts payable
|
$
|
356
|
$
|
342
|
||||
|
Accrued liabilities
|
350
|
283
|
||||||
|
Short-term lease liabilities
|
39
|
38
|
||||||
|
Long-term debt due within one year
|
58
|
38
|
||||||
|
Income taxes payable
|
2
|
1
|
||||||
|
Total current liabilities
|
805
|
702
|
||||||
|
Noncurrent Liabilities
|
||||||||
|
Long-term debt, net
|
$
|
3,263
|
$
|
2,988
|
||||
|
Pension and postretirement healthcare benefits
|
146
|
160
|
||||||
|
Asset retirement obligations
|
157
|
142
|
||||||
|
Environmental liabilities
|
67
|
65
|
||||||
|
Long-term lease liabilities
|
41
|
62
|
||||||
|
Deferred tax liabilities
|
176
|
184
|
||||||
|
Other long-term liabilities
|
42
|
49
|
||||||
|
Total liabilities
|
4,697
|
4,352
|
||||||
|
Commitments and Contingencies
|
||||||||
|
Shareholders’ Equity
|
||||||||
|
Tronox Holdings plc ordinary shares, par value $0.01 — 143,557,479 shares issued and outstanding at December 31, 2020 and 141,900,459 shares issued and outstanding at December 31, 2019
|
1
|
1
|
||||||
|
Capital in excess of par value
|
1,873
|
1,846
|
||||||
|
Retained Earnings (accumulated deficit)
|
434
|
(493
|
)
|
|||||
|
Accumulated other comprehensive loss
|
(610
|
)
|
(606
|
)
|
||||
|
Total Tronox Holdings plc shareholders’ equity
|
1,698
|
748
|
||||||
|
Noncontrolling interest
|
173
|
168
|
||||||
|
Total equity
|
1,871
|
916
|
||||||
|
Total liabilities and equity
|
$
|
6,568
|
$
|
5,268
|
||||
|
Year Ended December 31,
|
||||||||
|
2020
|
2019
|
|||||||
|
Cash Flows from Operating Activities:
|
||||||||
|
Net (loss) income
|
$
|
995
|
$
|
(97
|
)
|
|||
|
Net income (loss) from discontinued operations, net of tax
|
-
|
$
|
5
|
|||||
|
Net (loss) income from continuing operations
|
$
|
995
|
$
|
(102
|
)
|
|||
|
Adjustments to reconcile net (loss) income from continuing operations to net cash provided by operating activities, continuing operations:
|
||||||||
|
Depreciation, depletion and amortization
|
304
|
280
|
||||||
|
Deferred income taxes
|
(899
|
)
|
(9
|
)
|
||||
|
Share-based compensation expense
|
30
|
32
|
||||||
|
Amortization of deferred debt issuance costs and discount on debt
|
10
|
8
|
||||||
|
Loss on extinguishment of debt
|
2
|
3
|
||||||
|
Contract loss
|
-
|
19
|
||||||
|
Impairment loss
|
-
|
-
|
||||||
|
Acquired inventory step-up recognized in earnings
|
-
|
98
|
||||||
|
Other non-cash affecting net income (loss)
|
65
|
25
|
||||||
|
Changes in assets and liabilities:
|
||||||||
|
(Increase) decrease in accounts receivable, net
|
(49
|
)
|
78
|
|||||
|
(Increase) decrease in inventories, net
|
(21
|
)
|
(59
|
)
|
||||
|
(Increase) decrease in prepaid and other assets
|
(29
|
)
|
20
|
|||||
|
Increase (decrease) in accounts payable and accrued liabilities
|
17
|
67
|
||||||
|
Net changes in income tax payables and receivables
|
(2
|
)
|
(13
|
)
|
||||
|
Changes in other non-current assets and liabilities
|
(68
|
)
|
(35
|
)
|
||||
|
Cash provided by operating activities – continuing operations
|
355
|
412
|
||||||
|
Cash Flows from Investing Activities:
|
||||||||
|
Capital expenditures
|
(195
|
)
|
(198
|
)
|
||||
|
Cristal Acquisition
|
-
|
(1,675
|
)
|
|||||
|
Proceeds from sale of Ashtabula
|
-
|
701
|
||||||
|
Insurance proceeds
|
1
|
10
|
||||||
|
Proceeds from sale of businesses
|
-
|
-
|
||||||
|
Loans
|
(36
|
)
|
(25
|
)
|
||||
|
Proceeds from the sale of assets
|
1
|
2
|
||||||
|
Cash used in investing activities – continuing operations
|
(229
|
)
|
(1,185
|
)
|
||||
|
Cash Flows from Financing Activities:
|
||||||||
|
Repayments of short-term debt
|
(13
|
)
|
0
|
|||||
|
Repayments of long-term debt
|
(233
|
)
|
(387
|
)
|
||||
|
Proceeds from short-term debt
|
13
|
-
|
||||||
|
Proceeds from long-term debt
|
500
|
222
|
||||||
|
Repurchase of common stock
|
-
|
(288
|
)
|
|||||
|
Acquisition of noncontrolling interest
|
-
|
(148
|
)
|
|||||
|
Debt issuance costs
|
(10
|
)
|
(4
|
)
|
||||
|
Call premium paid
|
-
|
-
|
||||||
|
Dividends paid
|
(40
|
)
|
(27
|
)
|
||||
|
Restricted stock and performance-based shares settled in cash for taxes
|
(3
|
)
|
(6
|
)
|
||||
|
Proceeds from the exercise of warrants and options
|
-
|
-
|
||||||
|
Cash provided by (used in) financing activities – continuing operations
|
214
|
(638
|
)
|
|||||
|
Discontinued Operations:
|
||||||||
|
Cash provided by operating activities
|
-
|
29
|
||||||
|
Cash used in investing activities
|
-
|
(1
|
)
|
|||||
|
Net cash flows provided by discontinued operations
|
-
|
28
|
||||||
|
Effects of exchange rate changes on cash and cash equivalents and restricted cash
|
(3
|
)
|
(2
|
)
|
||||
|
Net increase (decrease) in cash and cash equivalents and restricted cash
|
337
|
(1,385
|
)
|
|||||
|
Cash and cash equivalents and restricted cash at beginning of period
|
311
|
1,696
|
||||||
|
Cash and cash equivalents and restricted cash at end of period - continuing operations
|
$
|
648
|
$
|
311
|
||||
|
Three Months Ended December 31,
|
Year Ended December 31,
|
|||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
Net income (loss) (U.S. GAAP)
|
$
|
57
|
$
|
(5
|
)
|
$
|
995
|
$
|
(97
|
)
|
||||||
|
Income from discontinued operations, net of tax (U.S. GAAP)
|
-
|
-
|
-
|
5
|
||||||||||||
|
Net income (loss) from continuing operations (U.S. GAAP)
|
$
|
57
|
$
|
(5
|
)
|
$
|
995
|
$
|
(102
|
)
|
||||||
|
Interest expense
|
49
|
47
|
189
|
201
|
||||||||||||
|
Interest income
|
(2
|
)
|
(2
|
)
|
(8
|
)
|
(18
|
)
|
||||||||
|
Income tax provision (benefit)
|
(5
|
)
|
4
|
(881
|
)
|
14
|
||||||||||
|
Depreciation, depletion and amortization expense
|
85
|
75
|
304
|
280
|
||||||||||||
|
EBITDA (non-U.S. GAAP)
|
184
|
119
|
599
|
375
|
||||||||||||
|
Inventory step-up (a)
|
-
|
3
|
-
|
98
|
||||||||||||
|
Contract loss (b)
|
-
|
-
|
-
|
19
|
||||||||||||
|
Share-based compensation (c)
|
11
|
8
|
30
|
32
|
||||||||||||
|
Transaction costs (d)
|
4
|
3
|
14
|
32
|
||||||||||||
|
Restructuring (e)
|
-
|
9
|
3
|
22
|
||||||||||||
|
Integration costs (f)
|
-
|
8
|
10
|
16
|
||||||||||||
|
Loss on extinguishment of debt (g)
|
2
|
1
|
2
|
3
|
||||||||||||
|
Foreign currency remeasurement (h)
|
6
|
(1
|
)
|
(4
|
)
|
(6
|
)
|
|||||||||
|
Pension settlement and curtailment gains (i)
|
(2
|
)
|
(1
|
)
|
(2
|
)
|
(1
|
)
|
||||||||
|
Charge for capital gains tax payment to Exxaro (j)
|
-
|
(2
|
)
|
-
|
4
|
|||||||||||
|
Insurance proceeds(k)
|
(8
|
)
|
-
|
(11
|
)
|
-
|
||||||||||
|
Other items (l)
|
7
|
9
|
27
|
21
|
||||||||||||
|
Adjusted EBITDA (non-U.S. GAAP)
|
$
|
204
|
$
|
156
|
$
|
668
|
$
|
615
|
||||||||
|
Consolidated
|
||||
|
Cash provided by operating activities - continuing operations
|
$
|
355
|
||
|
Capital expenditures
|
(195
|
)
|
||
|
Free cash flow (non-U.S. GAAP)
|
$
|
160
|
||
|
Proforma amounts
|
Proforma amounts
|
|||||||||||||||
|
Three Months Ended December 31,
|
Year Ended December 31,
|
|||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
Net sales
|
$
|
783
|
$
|
693
|
$
|
2,758
|
$
|
3,008
|
||||||||
|
Cost of goods sold
|
605
|
542
|
2,137
|
2,364
|
||||||||||||
|
Gross profit
|
178
|
151
|
621
|
644
|
||||||||||||
|
Selling, general and administrative expenses
|
84
|
92
|
347
|
354
|
||||||||||||
|
Restructuring
|
-
|
9
|
3
|
22
|
||||||||||||
|
Income from operations
|
94
|
50
|
271
|
268
|
||||||||||||
|
Interest expense
|
(49
|
)
|
(47
|
)
|
(189
|
)
|
(207
|
)
|
||||||||
|
Interest income
|
2
|
2
|
8
|
12
|
||||||||||||
|
Loss on extinguishment of debt
|
(2
|
)
|
(1
|
)
|
(2
|
)
|
(3
|
)
|
||||||||
|
Other expense, net
|
7
|
1
|
26
|
2
|
||||||||||||
|
Income from continuing operations before income taxes
|
52
|
5
|
114
|
72
|
||||||||||||
|
Income tax benefit (provision)
|
5
|
(4
|
)
|
881
|
(31
|
)
|
||||||||||
|
Net income from continuing operations
|
57
|
1
|
995
|
41
|
||||||||||||
|
Net income attributable to noncontrolling interest
|
12
|
5
|
26
|
23
|
||||||||||||
|
Net income from continuing operations attributable to Tronox Holdings plc
|
$
|
45
|
$
|
(4
|
)
|
$
|
969
|
$
|
18
|
|||||||
|
Net income from continuing operations per share, diluted
|
$
|
0.31
|
$
|
(0.03
|
)
|
$
|
6.69
|
$
|
0.12
|
|||||||
|
Weighted average shares outstanding, diluted (in thousands)
|
147,254
|
141,923
|
144,906
|
151,153
|
||||||||||||
|
Proforma amounts
|
Proforma amounts
|
|||||||||||||||
|
Three Months Ended December 31,
|
Year Ended December 31,
|
|||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
Net income from continuing operations attributable to Tronox Holdings plc (U.S. GAAP)
|
$
|
45
|
$
|
(4
|
)
|
$
|
969
|
$
|
18
|
|||||||
|
Transaction costs
|
4
|
-
|
14
|
-
|
||||||||||||
|
Restructuring
|
-
|
8
|
3
|
21
|
||||||||||||
|
Integration costs
|
-
|
8
|
10
|
16
|
||||||||||||
|
Loss on extinguishment of debt
|
2
|
1
|
2
|
3
|
||||||||||||
|
Pension settlement and curtailment gains
|
(2
|
)
|
(1
|
)
|
(2
|
)
|
(1
|
)
|
||||||||
|
Insurance proceeds
|
(8
|
)
|
-
|
(11
|
)
|
-
|
||||||||||
|
Other
|
2
|
-
|
4
|
-
|
||||||||||||
|
Tax valuation allowance
|
(10
|
)
|
-
|
(903
|
)
|
-
|
||||||||||
|
Income tax expense - deferred tax assets
|
(5
|
)
|
-
|
(5
|
)
|
-
|
||||||||||
|
Charge for capital gains tax payment to Exxaro
|
-
|
(2
|
)
|
-
|
4
|
|||||||||||
|
Adjusted net income attributable to Tronox Holdings plc (non-U.S. GAAP)
|
$
|
28
|
$
|
10
|
$
|
81
|
$
|
61
|
||||||||
|
Diluted net income per share from continuing operations (U.S. GAAP)
|
$
|
0.31
|
$
|
(0.03
|
)
|
$
|
6.69
|
$
|
0.12
|
|||||||
|
Transaction costs, per share
|
0.03
|
-
|
0.10
|
-
|
||||||||||||
|
Restructuring, per share
|
-
|
0.06
|
0.02
|
0.13
|
||||||||||||
|
Integration costs, per share
|
-
|
0.06
|
0.07
|
0.10
|
||||||||||||
|
Loss on extinguishment of debt, per share
|
0.01
|
0.01
|
0.01
|
0.02
|
||||||||||||
|
Pension settlement and curtailment gains, per share
|
(0.01
|
)
|
(0.01
|
)
|
(0.01
|
)
|
(0.01
|
)
|
||||||||
|
Insurance proceeds, per share
|
(0.05
|
)
|
-
|
(0.08
|
)
|
-
|
||||||||||
|
Other, per share
|
0.01
|
-
|
0.03
|
-
|
||||||||||||
|
Tax valuation allowance, per share
|
(0.07
|
)
|
-
|
(6.24
|
)
|
-
|
||||||||||
|
Income tax expense - deferred tax assets, per share
|
(0.04
|
)
|
-
|
(0.03
|
)
|
-
|
||||||||||
|
Charge for capital gains tax payment to Exxaro, per share
|
-
|
(0.02
|
)
|
-
|
0.03
|
|||||||||||
|
Diluted adjusted net income per share attributable to Tronox Holdings plc (non-U.S. GAAP)
|
$
|
0.19
|
$
|
0.07
|
$
|
0.56
|
$
|
0.39
|
||||||||
|
Weighted average shares outstanding, diluted (in thousands)
|
147,254
|
143,124
|
144,906
|
151,153
|
||||||||||||
|
Three Months Ended December 31,
|
Year Ended December 31,
|
|||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
Net income from continuing operations (U.S. GAAP)
|
$
|
57
|
$
|
1
|
$
|
995
|
$
|
41
|
||||||||
|
Interest expense
|
49
|
47
|
189
|
207
|
||||||||||||
|
Interest income
|
(2
|
)
|
(2
|
)
|
(8
|
)
|
(12
|
)
|
||||||||
|
Income tax provision (benefit)
|
(5
|
)
|
4
|
(881
|
)
|
31
|
||||||||||
|
Depreciation, depletion and amortization expense
|
85
|
75
|
304
|
323
|
||||||||||||
|
EBITDA (non-U.S. GAAP)
|
184
|
125
|
599
|
590
|
||||||||||||
|
Inventory step-up
|
-
|
-
|
-
|
-
|
||||||||||||
|
Share-based compensation
|
11
|
8
|
30
|
32
|
||||||||||||
|
Transaction costs
|
4
|
-
|
14
|
-
|
||||||||||||
|
Restructuring
|
-
|
9
|
3
|
22
|
||||||||||||
|
Integration costs
|
-
|
8
|
10
|
16
|
||||||||||||
|
Loss on extinguishment of debt
|
2
|
1
|
2
|
3
|
||||||||||||
|
Foreign currency remeasurement
|
6
|
(1
|
)
|
(4
|
)
|
(6
|
)
|
|||||||||
|
Pension settlement and curtailment gains
|
(2
|
)
|
(1
|
)
|
(2
|
)
|
(1
|
)
|
||||||||
|
Charge for capital gains tax payment to Exxaro
|
-
|
(2
|
)
|
-
|
4
|
|||||||||||
|
Insurance proceeds
|
(8
|
)
|
-
|
(11
|
)
|
-
|
||||||||||
|
Other items
|
7
|
9
|
27
|
21
|
||||||||||||
|
Adjusted EBITDA (non-U.S. GAAP)
|
$
|
204
|
$
|
156
|
$
|
668
|
$
|
681
|
||||||||